Aapharmasyn LLC
Ann Arbor, MI Part of Aprc Corp
- UEI
- YUFFPW8FVKX2
- CAGE
- 6NX94
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
G7MZE43E6Q68
-
Parent
G7MZE43E6Q68
- SAM.gov registration date
- Physical address
- 3915 Research Park Dr #1A, Ann Arbor, MI 48108, USA
- Website
- aapharmasyn.com
- Founded
- 2006
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Materials
- Chemicals
- Commodity Chemicals
- SIC code
- 73 Business Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $728,079 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $728,079 |
Contract vehicles
No active vehicles.
1 expired vehicle
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Aapharmasyn LLC, doing business as AAP, is a small disadvantaged business based in Ann Arbor, Michigan that provides experimental therapeutics medicinal chemistry and interventional agents chemistry research and development services to federal agencies as a prime contractor exclusively. The firm operates as a child entity of Aprc Corp and competes full-and-open rather than under set-aside vehicles.
AAP's federal footprint centers on three customer agencies, with the National Institute of Allergy and Infectious Diseases (NIAID) anchoring 86% of combined potential value. In September 2025, NIAID awarded AAP a single-award indefinite-delivery contract with a $50 million ceiling through September 2032 for interventional agents chemistry agents, under which two delivery orders have been issued to date: a $147,236 firm-fixed-price order under Task Area B (completion July 29, 2026) and a $1,127,656 cost-plus-fixed-fee order (completion March 23, 2027). Both orders are performed at the Ann Arbor location. The Army Medical Command has placed seven awards totaling $7.7 million combined potential value across two primary vehicles (the Army's W81XWH12D0028 IDIQ and an Experimental Therapeutics Medicinal Chemistry vehicle), while the Defense Health Agency has placed two awards totaling $160 thousand. AAP works exclusively in a prime role across its twelve recorded awards spanning 2012 to June 2026.
The vendor's capability portfolio aligns with biotechnology and nanotechnology R&D, with awards coded primarily to Research and Development in Biotechnology (5 awards) and Research and Development in Nanotechnology (4 awards). Only $1.3 million in combined potential value faces recompete in the next twenty-four months; the bulk of exposure sits under the NIAID IDIQ's seven-year term. Total obligated dollars across all awards stand at $1.1 million against $59.1 million in combined potential value, reflecting the recent character of the IDIQ award and its delivery-order execution model.
SBA capabilities narrative
We specializes in custom synthesis and contract research. We offer our customers a broad range of services which include first-time synthesis of complex and commercially not available compounds, optimization of synthetic routes and supply of exclusive chemicals amongst others. Our team tackled multi-step syntheses of complex molecules, including chemical intermediates, drug metabolites, process impurities, degradants, reference compounds, preclinical drug candidates, and other organic molecules.
Quick answers
Is Aapharmasyn LLC registered in SAM.gov?
Yes. Aapharmasyn LLC's SAM.gov registration is active through July 27, 2027.
Which contract vehicles does Aapharmasyn LLC hold?
Aapharmasyn LLC holds a place on 1 federal contract vehicle: Experimental Therapeutics Medicinal Chemistry.
How much has Aapharmasyn LLC received in federal contracts?
Federal contracts obligated $728,079 to Aapharmasyn LLC in fiscal years 2023 through 2027.
What is Aapharmasyn LLC's most recent federal award?
Aapharmasyn LLC's most recent federal contract award is Interventional agents chemistry services (75N93026F00002), from National Institute of Allergy and Infectious Diseases (NIH), on June 24, 2026.
On GovTribe
See Aapharmasyn LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors